Aurora Spine Secures Two U.S. Patents to Strengthen Innovation Strategy
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 08 2026
0mins
Should l Buy ASG?
Source: Globenewswire
- Patent Protection Enhancement: Aurora Spine has secured U.S. Patent No. 12,478,411 B2, further expanding the protected design space of the ZIP™ implant family, marking the tenth patent for this platform and enhancing the company's competitive edge in the spine surgery market.
- Innovative Technology Breakthrough: The new patent, No. 12,478,481 B2, focuses on selecting orthopedic implants based on bone density scan results, establishing a data-driven framework that enables surgeons to choose implants according to patient bone quality, thereby improving surgical precision.
- Diverse Innovation Pathways: The simultaneous issuance of these two patents underscores Aurora Spine's ongoing investment in multiple innovation pathways, supporting future product development and enhancing clinical differentiation, which in turn boosts shareholder value.
- Industry Leadership Position: Aurora Spine's innovative patents not only address biomechanical challenges in spine surgery but also solidify its leadership position in the spinal implant market by providing simplified and effective solutions that advance patient care.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ASG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ASG
Wall Street analysts forecast ASG stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 5.200
Low
Averages
High
Current: 5.200
Low
Averages
High

No data
About ASG
Liberty All-Star Growth Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to seek long-term capital appreciation. Under normal market conditions, the Fund seeks to achieve its investment objective through investing at least 65% of its net assets in a diversified portfolio of equity securities of companies of any market capitalization. The Fund may invest up to 35% of the value of its total assets in United States (U.S.) Government Securities, repurchase agreements with respect to U.S. Government Securities, and, to an extent not greater than 10% of the market value of the Fund's total assets, money market mutual funds that invest primarily in U.S. Government Securities. The Fund's investment advisor is ALPS Advisors, Inc. The Fund's investment managers include Congress Asset Management Company, LLP; Sustainable Growth Advisers, LP, and Weatherbie Capital LLC.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Small-Cap Appeal: Amid modest gains in Chinese stocks and economic shifts in Japan, small-cap companies are gaining attention, particularly those aligning with current economic conditions, indicating rising investor interest in this segment.
- Cogstate Performance Boost: Cogstate anticipates a revenue of A$26.9 million for the first half of 2026, reflecting a 12% increase from prior projections, showcasing strong performance in clinical trials and insider confidence.
- Semirara Coal and Power: Semirara Mining and Power generates approximately ₱41.39 billion from coal and ₱24.11 billion from power, and despite risks from external borrowing, insider stock purchases indicate confidence in future growth prospects.
- ESR-REIT Recovery: ESR-REIT reported sales of S$446 million and a net income of S$32 million for 2025, rebounding from significant losses, with projected annual growth exceeding 32%, although it still relies on external financing.
See More
- Portfolio Overview: As of January 2026, the Liberty All-Star Growth Fund reports a total net asset value of $362.8 million, with a 100.5% equity investment ratio, indicating a comprehensive investment strategy across various market segments.
- Top Holdings Analysis: The top 20 holdings constitute 37.7% of the fund's equity portfolio, with NVIDIA, Apple, and Alphabet representing 4.7%, 2.9%, and 2.8% respectively, reflecting a strong concentration in technology stocks.
- Monthly Performance Review: The fund achieved a total return of 0.71% in January, while the market price increased by 1.32%, demonstrating relative stability amidst market fluctuations, despite facing a 9.0% discount.
- New and Liquidated Holdings: New holdings include Arista Networks and Expedia, while AMD and Bank of America were liquidated, indicating the fund's proactive adjustments to its investment portfolio in response to market dynamics.
See More
- Investment Strategy Overview: The Liberty All-Star Growth Fund employs an all-cap growth investment style, combining three distinct investment managers focused on small, mid, and large-cap stocks, ensuring portfolio diversity and risk management.
- Monthly Performance Data: As of the end of January, the fund's net asset value (NAV) stood at $5.77 with a market price of $5.25, reflecting a 9.0% discount, while the monthly performance was 0.71%, indicating the impact of market fluctuations on the fund.
- Portfolio Structure Analysis: The top 20 holdings account for 37.7% of the total equity portfolio, with NVIDIA, Apple, and Alphabet being the largest investments, highlighting a significant concentration in the technology sector that may influence future growth potential.
- New and Liquidated Holdings: New holdings include Arista Networks and Expedia, while positions in AMD and Bank of America were liquidated, indicating the fund's dynamic adjustment of its portfolio to adapt to market changes.
See More
- Investment Strategy Overview: The Liberty All-Star Growth Fund employs an all-cap growth investment style, combining three investment managers with distinct capitalization focuses—small, mid, and large-cap—to ensure portfolio diversity and risk management.
- Monthly Performance Data: As of the end of January, the fund's net asset value (NAV) stood at $5.77, with a market price of $5.25, reflecting a 9.0% discount; however, the monthly performance rebounded by 0.71%, indicating the impact of market fluctuations.
- Portfolio Changes: New holdings include companies like Arista Networks and Expedia, while positions in AMD and Bank of America were liquidated, demonstrating the fund's strategy of dynamically adjusting its portfolio to adapt to market changes.
- Sector Distribution Analysis: The fund's portfolio shows a significant concentration in high-growth sectors, with Information Technology and Industrials comprising 26.7% and 25.4% respectively, indicating a strategic focus on capturing future growth opportunities in these industries.
See More

- Investment Overview: The Liberty All-Star Growth Fund employs an all-cap growth investment strategy, combining three distinct capitalization-focused investment managers to ensure portfolio diversity and risk management.
- Holding Performance: As of December, the top 20 holdings account for 38.0% of the total equity portfolio, with NVIDIA, Apple, and Microsoft representing 5.0%, 3.7%, and 3.1% respectively, indicating a strong preference for technology stocks.
- Monthly Performance: The fund's net asset value (NAV) decreased from $5.99 at the beginning of the month to $5.86, resulting in a monthly performance of -2.17%, reflecting market volatility's impact on fund value, while year-to-date performance stands at 4.58%, showcasing long-term growth potential.
- Asset Allocation: As of December, 99.8% of the fund's assets are invested in equities, with information technology and industrials comprising 28.6% and 22.7% respectively, indicating a concentrated investment strategy in high-growth sectors.
See More
- Patent Protection Enhancement: Aurora Spine has secured U.S. Patent No. 12,478,411 B2, further expanding the protected design space of the ZIP™ implant family, marking the tenth patent for this platform and enhancing the company's competitive edge in the spine surgery market.
- Innovative Technology Breakthrough: The new patent, No. 12,478,481 B2, focuses on selecting orthopedic implants based on bone density scan results, establishing a data-driven framework that enables surgeons to choose implants according to patient bone quality, thereby improving surgical precision.
- Diverse Innovation Pathways: The simultaneous issuance of these two patents underscores Aurora Spine's ongoing investment in multiple innovation pathways, supporting future product development and enhancing clinical differentiation, which in turn boosts shareholder value.
- Industry Leadership Position: Aurora Spine's innovative patents not only address biomechanical challenges in spine surgery but also solidify its leadership position in the spinal implant market by providing simplified and effective solutions that advance patient care.
See More








